| dbo:abstract |
بافيتوكسيماب هو جسم مضاد وحيد النسيلة في طور التجارب السريرية لأجل استخدامه في علاج السرطان والأمراض الفيروسية. (ar) Bavituximab (PGN401) is a human-mouse chimeric monoclonal antibody against phosphatidylserine, which is a component of cell membranes that is exposed when a cell is transformed into solid tumor cancer cell or dies, and when cells are infected with hepatitis C. The process of cell death is highly controlled and so there usually no immune response to phosphatidylserine but when bavituximab binds to it, the conjugate appears to stimulate an immune response in humans. (en) Il Bavituximab è un anticorpo monoclonale chimerico, che è stato sperimentato come trattamento di tumori e infezioni virali.Il farmaco lega la fosfatidilserina che viene esposta sulla superficie di cellule animali atipiche, sui tumori e su sei differenti famiglie di virus. (it) |
| dbo:casNumber |
648904-28-3 |
| dbo:fdaUniiCode |
Q16CT95N25 |
| dbo:wikiPageID |
9124162 (xsd:integer) |
| dbo:wikiPageLength |
7640 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
1084697175 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbr:Non-small_cell_lung_cancer dbr:Monoclonal_antibody dbc:Experimental_cancer_drugs dbr:Apoptosis dbr:Hepatitis_C dbr:Hepatocellular_carcinoma dbc:Monoclonal_antibodies_for_tumors dbr:Phosphatidylserine dbr:Influenza dbr:Malignant_transformation dbr:Solid_tumor dbr:Chimera_(protein) dbr:Lassa_fever_virus |
| dbp:atcPrefix |
none (en) |
| dbp:c |
6446 (xsd:integer) |
| dbp:casNumber |
648904 (xsd:integer) |
| dbp:chemspiderid |
none (en) |
| dbp:eliminationHalfLife |
108000.0 |
| dbp:h |
9946 (xsd:integer) |
| dbp:mabType |
mab (en) |
| dbp:n |
1702 (xsd:integer) |
| dbp:o |
2042 (xsd:integer) |
| dbp:routesOfAdministration |
infusion (en) |
| dbp:s |
42 (xsd:integer) |
| dbp:source |
xi/o (en) |
| dbp:target |
dbr:Phosphatidylserine |
| dbp:type |
mab (en) |
| dbp:unii |
Q16CT95N25 (en) |
| dbp:verifiedrevid |
455435138 (xsd:integer) |
| dbp:wikiPageUsesTemplate |
dbt:Drugbox dbt:Reflist dbt:Rp dbt:Short_description dbt:Cascite dbt:Chemspidercite dbt:Drugbankcite dbt:Fdacite dbt:Monoclonals_for_tumors |
| dcterms:subject |
dbc:Experimental_cancer_drugs dbc:Monoclonal_antibodies_for_tumors |
| rdf:type |
owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:MonoclonalAntibody dbo:Drug |
| rdfs:comment |
بافيتوكسيماب هو جسم مضاد وحيد النسيلة في طور التجارب السريرية لأجل استخدامه في علاج السرطان والأمراض الفيروسية. (ar) Bavituximab (PGN401) is a human-mouse chimeric monoclonal antibody against phosphatidylserine, which is a component of cell membranes that is exposed when a cell is transformed into solid tumor cancer cell or dies, and when cells are infected with hepatitis C. The process of cell death is highly controlled and so there usually no immune response to phosphatidylserine but when bavituximab binds to it, the conjugate appears to stimulate an immune response in humans. (en) Il Bavituximab è un anticorpo monoclonale chimerico, che è stato sperimentato come trattamento di tumori e infezioni virali.Il farmaco lega la fosfatidilserina che viene esposta sulla superficie di cellule animali atipiche, sui tumori e su sei differenti famiglie di virus. (it) |
| rdfs:label |
بافيتوكسيماب (ar) Bavituximab (en) Bavituximab (it) |
| owl:sameAs |
yago-res:Bavituximab wikidata:Bavituximab dbpedia-ar:Bavituximab dbpedia-it:Bavituximab https://global.dbpedia.org/id/3M5ZX |
| prov:wasDerivedFrom |
wikipedia-en:Bavituximab?oldid=1084697175&ns=0 |
| foaf:isPrimaryTopicOf |
wikipedia-en:Bavituximab |
| is dbo:wikiPageRedirects of |
dbr:C6446H9946N1702O2042S42 |
| is dbo:wikiPageWikiLink of |
dbr:Monoclonal_antibody dbr:C6446H9946N1702O2042S42 dbr:Ipilimumab dbr:Humanized_antibody dbr:List_of_therapeutic_monoclonal_antibodies dbr:List_of_drugs:_Ba |
| is foaf:primaryTopic of |
wikipedia-en:Bavituximab |